Calico Life Sciences at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Calico Life Sciences brings 2 presentations to ENA 2026 in Barcelona. Its posters span AI-driven target selection and the tumor microenvironment. SPOT is a multi-agent AI platform that prioritizes oncology drug targets on the evidence, and separate work finds the integrated stress response drives an immunosuppressive tumor microenvironment that 2BAct can target.
| Organization | ENA 2026 Attendance |
|---|---|
Calico Life Sciences South San Francisco, CA | |
Alphabet-founded company researching the biology of ageing and developing drugs for age-related diseases, including cancer. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm |
Instantly find 20 buyers from Calico Life Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction